13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q3 2020. See the latest, Q2 2026 →

Reported value

$333.11B

+5.4% on the quarter before

Positions

405

28 new · 22 sold out

Top 10

33.7%

of the value

Est. gain

+$18.61B

on stocks held all quarter

Est. return

+6.3%

on those stocks since Q2 2020

Filed

Nov 13, 2020

On SEC EDGAR ↗

Positions as of Sep 30, 2020, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 50% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2020. Striped tiles are options.

Microsoft5.9%Netflix4.6%Meta4.3%Amazon3.8%Broadcom3.6%
Abbott Labs2.9%
Amgen Inc2.6%
Gilead Sciences Inc2.2%
Unitedhealth Group Inc2.1%
Mastercard1.8%
Home Depot Inc1.6%
Comcast Corp New1.6%
Thermo Fisher Scientific Inc1.5%
Alphabet1.5%
Philip Morris Intl Inc1.4%
Alphabet1.2%
Csx Corp1.2%
Apple1.2%
Abbvie Inc1.1%
Linde Plc1.0%
MercadoLibre0.9%Dominion Energy0.8%
Accenture Plc Ireland0.8%
ServiceNow0.8%

Largest buys

Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Comcast Corp New~$1.97BAdded · 0.9% → 1.6%+42,483,174 shares
  2. Burlington Stores Inc~$1.07BAdded · 0.1% → 0.4%+5,176,166 shares
  3. Philip Morris Intl Inc~$759.1MAdded · 1.1% → 1.4%+10,122,279 shares
  4. Apple~$726.3MAdded · 1.1% → 1.2%+6,271,851 shares
  5. General Mtrs Co~$672.9MAdded · 0.4% → 0.6%+22,741,666 shares
  6. Jpmorgan Chase & Co~$665.6MAdded · 0.5% → 0.7%+6,914,372 shares
  7. Raytheon Technologies Corp~$537.8MAdded · 0.6% → 0.7%+9,345,820 shares
  8. Xp Inc~$520.9MAdded · 0.1% → 0.2%+12,495,821 shares
  9. D R Horton Inc~$520.4MAdded · 0.1% → 0.3%+6,881,322 shares
  10. Toronto Dominion Bk Ont~$490.2MAdded · 0.3% → 0.4%+10,587,077 shares

Largest sells

Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Meta~$2.75BCut · 4.7% → 4.3%−10,518,227 shares
  2. Netflix~$1.61BCut · 4.9% → 4.6%−3,229,728 shares
  3. MercadoLibre~$1.12BCut · 1.2% → 0.9%−1,030,640 shares
  4. Illumina Inc~$1.05BCut · 0.5% → 0.1%−3,393,579 shares
  5. Amazon~$974.3MCut · 3.8% → 3.8%−309,441 shares
  6. Autodesk~$845.3MCut · 1.1% → 0.7%−3,659,216 shares
  7. PayPal~$665.0MCut · 0.9% → 0.7%−3,374,965 shares
  8. Gilead Sciences Inc~$520.9MCut · 3.1% → 2.2%−8,243,635 shares
  9. L3harris Technologies Inc~$508.9MCut · 0.4% → 0.3%−2,996,320 shares
  10. Coca Cola Co~$492.4MCut · 0.5% → 0.3%−9,973,846 shares

Holdings

As of Sep 30, 2020. Changes are in shares against Jun 30, 2020, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares −0.08% · price +3.4%5.9%$19.77B+$641.2M
NetflixCOM · shares −9.5% · price +9.9%4.6%$15.44B+$1.39B
MetaCL A · shares −16% · price +15.3%4.3%$14.33B+$1.91B
AmazonCOM · shares −7.2% · price +14.1%3.8%$12.65B+$1.57B
BroadcomCOM · shares +1.9% · price +15.4%3.6%$11.97B+$1.57B
Abbott LabsCOM · shares −0.00% · price +19.0%2.9%$9.51B+$1.52B
Amgen IncCOM · shares +0.4% · price +7.8%2.6%$8.51B+$610.5M
Gilead Sciences IncCOM · shares −6.6% · price −17.9%2.2%$7.40B−$1.61B
Unitedhealth Group IncCOM · shares −3.1% · price +5.7%2.1%$6.92B+$373.3M
MastercardCL A · shares +8.9% · price +14.4%1.8%$5.88B+$677.6M
Home Depot IncCOM · shares −1.6% · price +10.9%1.6%$5.27B+$515.9M
Comcast Corp NewCL A · shares +60% · price +18.7%1.6%$5.21B+$511.3M
Thermo Fisher Scientific IncCOM · shares −0.7% · price +21.9%1.5%$5.11B+$916.7M
AlphabetCAP STK CL A · shares +5.2% · price +3.4%1.5%$4.88B+$150.6M
Philip Morris Intl IncCOM · shares +20% · price +7.0%1.4%$4.59B+$252.1M
AlphabetCAP STK CL C · shares +0.6% · price +4.0%1.2%$4.16B+$157.5M
Csx CorpCOM · shares +4.0% · price +11.4%1.2%$4.02B+$394.8M
AppleCOM · shares +22% · price −4.8%1.2%$4.00B−$163.6M
Abbvie IncCOM · shares −11% · price −10.8%1.1%$3.57B−$432.1M
Linde PlcSHS · shares −4.7% · price +12.3%0.99%$3.30B+$360.5M
MercadoLibreCOM · shares −26% · price +9.8%0.94%$3.14B+$280.2M
Dominion EnergyCOM · shares +3.0% · price −2.8%0.85%$2.83B−$78.2M
Accenture Plc IrelandSHS CLASS A · shares −1.9% · price +5.2%0.85%$2.82B+$140.5M
ServiceNowCOM · shares −0.7% · price +19.7%0.83%$2.75B+$453.1M
Eog Res IncCOM · shares −0.4% · price −29.1%0.77%$2.55B−$1.05B
Total · 405 positions100%$333.11B+$18.61B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2020 to Q3 2020: 377 stocks held throughout, up $18.61B (+6.3%).

  1. Meta+$1.91B+15%
  2. Broadcom+$1.57B+15%
  3. Amazon+$1.57B+14%
  4. Abbott Labs+$1.52B+19%
  5. Netflix+$1.39B+10%
  6. Teva Pharmaceutical Inds Ltd−$432.0M−27%
  7. Abbvie Inc−$432.1M−11%
  8. Biomarin Pharmaceutical Inc−$1.04B−38%
  9. Eog Res Inc−$1.05B−29%
  10. Gilead Sciences Inc−$1.61B−18%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.